Inovio Pharmaceuticals Inc
F:GBM
Inovio Pharmaceuticals Inc
F:GBM
Price:
0.59
EUR
1.2%
Market Cap:
€40.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inovio Pharmaceuticals Inc
F:GBM
|
US |
|
P
|
Parsons Corp
F:59P
|
US |
|
S
|
Southwestern Energy Co
F:SW5
|
US |
|
K
|
Kikkoman Corp
XBER:KIK
|
JP |
|
Unibail-Rodamco-Westfield SE
AEX:URW
|
FR |
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
US |
|
Maxell Ltd
OTC:MXLLF
|
JP |
|
A
|
Archer-Daniels-Midland Co
DUS:ADM
|
US |
|
United Microelectronics Corp
TWSE:2303
|
TW |
|
V
|
Vinhomes JSC
VN:VHM
|
VN |
|
B
|
Bank Handlowy w Warszawie SA
XMUN:6HW
|
PL |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of GBM.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GBM
Multiples-Based Value
Base Case
Not Available
